ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Hematology Oncology

Top Hematology Oncology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD BARYLAK MD

Hematology Oncology

4,105

$297K

175
134 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$72
Average prescription price

Avg: $356

ANDREW YETTER MD

Hematology Oncology

3,311

$231K

195
155 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$70
Average prescription price

Avg: $356

OSAMA HALAWEH MD

Hematology Oncology

2,782

$405K

184
149 are 65+

23%
patients receiving schedule two controlled substances

Avg: 13%

17%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$146
Average prescription price

Avg: $356

JONATHAN TREISMAN M. D.

Hematology Oncology

2,548

$716K

257
202 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$281
Average prescription price

Avg: $356

DAVID MERTENS MD

Hematology Oncology

2,039

$336K

166
139 are 65+

8%
patients receiving schedule two controlled substances

Avg: 13%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$165
Average prescription price

Avg: $356

MALIK BANDEALY MD

Hematology Oncology

1,830

$580K

260
201 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 15%

$317
Average prescription price

Avg: $356

TIMOTHY GOGGINS M.D.

Hematology Oncology

1,780

$683K

234
197 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$384
Average prescription price

Avg: $356

FEDERICO SANCHEZ M.D.

Hematology Oncology

1,708

$583K

181
159 are 65+

23%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 15%

$342
Average prescription price

Avg: $356

MARGERY HOWARD M.D.

Hematology Oncology

1,697

$504K

224
184 are 65+

20%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$297
Average prescription price

Avg: $356

HARISH AHUJA MD

Hematology Oncology

1,689

$861K

180
145 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$510
Average prescription price

Avg: $356

ANTHONY JASLOWSKI M.D.

Hematology Oncology

1,681

$315K

231
185 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$187
Average prescription price

Avg: $356

SYED HAIDER MD

Hematology Oncology

1,643

$718K

230
186 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 15%

$437
Average prescription price

Avg: $356

WILLIAM GUENTHER M.D.

Hematology Oncology

1,623

$525K

240
206 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$324
Average prescription price

Avg: $356

DAVID SCHIFELING MD

Hematology Oncology

1,576

$370K

137
98 are 65+

23%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$235
Average prescription price

Avg: $356

YOUNG CHOI MD

Hematology Oncology

1,489

$417K

161
126 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 15%

$280
Average prescription price

Avg: $356

KAREN GREMMINGER M.D.

Hematology Oncology

1,465

$165K

206
181 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$112
Average prescription price

Avg: $356

CHRISTOPHER PETERSON MD

Hematology Oncology

1,463

$420K

185
159 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$287
Average prescription price

Avg: $356

ROBERT TAYLOR MD

Hematology Oncology

1,430

$782K

155
134 are 65+

19%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 15%

$547
Average prescription price

Avg: $356

MICHAEL VOLK M.D.

Hematology Oncology

1,420

$681K

169
126 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 15%

$480
Average prescription price

Avg: $356

HAMIED REZAZADEH MD

Hematology Oncology

1,408

$291K

164
142 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$207
Average prescription price

Avg: $356

SANA JEFFREYS MD

Hematology Oncology

1,396

$359K

193
166 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$257
Average prescription price

Avg: $356

SANDEEP BASU MD

Hematology Oncology

1,388

$325K

217
187 are 65+

10%
patients receiving schedule two controlled substances

Avg: 13%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$234
Average prescription price

Avg: $356

WALTER VOGEL MD

Hematology Oncology

1,371

$381K

148
109 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

16%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 15%

$278
Average prescription price

Avg: $356

RAYMOND KNIGHT MD

Hematology Oncology

1,331

$340K

85
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$256
Average prescription price

Avg: $356

MICHAEL FRONTIERA MD

Hematology Oncology

1,281

$247K

219
181 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$193
Average prescription price

Avg: $356

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank